Defender Capital LLC. Has $11.68 Million Stock Position in STAAR Surgical Company $STAA

Key Points

• Defender Capital LLC has reduced its stake in STAAR Surgical Company by 3.4%, now holding 695,764 shares valued at approximately $11.68 million.
• Institutional investors significantly increased their positions in STAAR Surgical, with CWM LLC growing its stake by 74.1% in the second quarter.
• Equities analysts have set new price targets for STAAR, with a consensus target price of $20.67 and numerous analysts maintaining a "hold" rating on the stock.

Defender Capital LLC. lessened its stake in STAAR Surgical Company (NASDAQ:STAA - Free Report) by 3.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 695,764 shares of the medical instruments supplier's stock after selling 24,768 shares during the period. STAAR Surgical accounts for 4.0% of Defender Capital LLC.'s portfolio, making the stock its 10th biggest holding. Defender Capital LLC. owned about 1.40% of STAAR Surgical worth $11,675,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of STAA. CWM LLC grew its position in STAAR Surgical by 74.1% in the 2nd quarter. CWM LLC now owns 1,563 shares of the medical instruments supplier's stock valued at $26,000 after buying an additional 665 shares in the last quarter. US Bancorp DE boosted its position in shares of STAAR Surgical by 1,693.0% during the 1st quarter. US Bancorp DE now owns 2,044 shares of the medical instruments supplier's stock valued at $36,000 after purchasing an additional 1,930 shares in the last quarter. Brooklyn Investment Group boosted its position in shares of STAAR Surgical by 1,564.0% during the 1st quarter. Brooklyn Investment Group now owns 2,679 shares of the medical instruments supplier's stock valued at $47,000 after purchasing an additional 2,518 shares in the last quarter. EntryPoint Capital LLC bought a new position in shares of STAAR Surgical during the 1st quarter valued at about $189,000. Finally, Strs Ohio bought a new position in shares of STAAR Surgical during the 1st quarter valued at about $190,000. Institutional investors own 96.70% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Mizuho raised their price objective on shares of STAAR Surgical from $17.00 to $18.00 and gave the company a "neutral" rating in a research report on Wednesday, July 16th. Canaccord Genuity Group raised their price objective on shares of STAAR Surgical from $20.00 to $28.00 and gave the company a "hold" rating in a research report on Wednesday, August 6th. Stifel Nicolaus set a $28.00 price objective on shares of STAAR Surgical and gave the company a "hold" rating in a research report on Thursday, August 7th. Piper Sandler upgraded shares of STAAR Surgical to a "hold" rating in a research report on Wednesday, June 18th. Finally, Weiss Ratings restated a "sell (d)" rating on shares of STAAR Surgical in a research report on Wednesday, October 8th. Ten research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Reduce" and a consensus target price of $20.67.

STAAR Surgical Price Performance

Shares of STAA opened at $27.25 on Tuesday. STAAR Surgical Company has a one year low of $13.50 and a one year high of $33.28. The company has a 50-day moving average of $27.35 and a two-hundred day moving average of $21.03. The stock has a market cap of $1.34 billion, a price-to-earnings ratio of -14.12 and a beta of 0.82.

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.

Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical Company (NASDAQ:STAA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.